• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cerulean Pharma Inc

+ Add to Watchlist

122:GR

2.954 EUR 0.101 3.31%

As of 02:06:10 ET on 09/16/2014.

Snapshot for Cerulean Pharma Inc (122)

Open: 2.953 Day's Range: 2.953 - 2.954 Volume: 0
Previous Close: 3.055 52wk Range: 2.484 - 5.234 1-Yr Rtn: -

Stock Chart for 122

No chart data available.
  • 122:GR 2.953
  • 1D
  • 1M
  • 1Y
3.055
Interactive 122 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 122

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.9050
Est. PEG Ratio -
Market Cap (M EUR) 59.45
Shares Outstanding (M) 20.12
30 Day Average Volume 72
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 122

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 122

Cerulean Pharma, Inc. designs and develops pharmaceutical products. The Company manufactures therapeutics in the areas of oncology, cardiovascular, autoimmune, and inflammatory diseases as well as tumor cells. Cerulean Pharma operates in the United States.

Oliver S FetzerPresident/CEOEdward GarmeySenior VP/Chief Medical Ofcr
Christopher Damien T Guiffre "Chris"Senior VP/Chief Business OfcrJean SilveriSenior VP/General Counsel
More Company Profile & Key Executives for 122

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil